CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

COVID19 vaccineWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)

Name (Synonyms) Correlation
drug2933 online mindfulness group Wiki 1.00
drug2176 Saline Wiki 0.38

Correlated MeSH Terms (2)

Name (Synonyms) Correlation
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 A Randomised, Controlled, Phase 1 Study to Evaluate the Safety and Immunogenicity of a Candidate Adjuvanted Recombinant Protein SARS-COV-2 Vaccine in Healthy Adult Subjects

This is a study to test a new vaccine (Covax-19) against COVID-19. COVID-19 is a potentially deadly disease that is caused by a new strain of coronavirus called SARS-CoV-2. To date, SARS-CoV-2 has infected over 4 million people worldwide resulted in the deaths of over three hundred thousand people.

NCT04453852 Coronavirus Infection COVID Biological: COVID19 vaccine Biological: Saline
MeSH:Coronavirus Infections Severe Acute Respiratory Syndrome

Primary Outcomes

Description: Incidence of Adverse Events 1 week post immunisation

Measure: Incidence of Adverse Events

Time: 1 weeks post immunisation

Description: COVID19 neutralizing antibody titers post immunisation

Measure: COVID19 neutralizing antibody titers

Time: 2 weeks post second immunisation

Description: Frequency of COVID19 spike specific T cells 3 weeks post second immunisation

Measure: COVID19 T cell immunogenicity

Time: 3 weeks post second immunisation

Secondary Outcomes

Description: COVID19 spike specific antibody titers 6 months post second immunisation

Measure: Durability of antibody response

Time: 6 months post immunisation

No related HPO nodes (Using clinical trials)